ADDITION OF PEGINTERFERON ALFA-2a INCREASES HBsAg DECLINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL. (PAS STUDY)

被引：0
|
作者：
Farag, Mina S. [1 ,2 ]
Fung, Scott K. [1 ]
Van Campenhout, Margo [3 ]
Van Erpecum, Karel J. [4 ]
Wong, David K. H. [1 ]
Boonstra, Andre [5 ]
Verhey, Elke [3 ]
De Man, Robert A. [3 ]
Liem, Kin Seng [1 ,3 ]
Hansen, Bettina E. [1 ,6 ]
Janssen, Harry L. A. [1 ]
机构：
[1] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto Gen Hosp, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[5] Erasmus Univ, Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
195
引用
收藏
页码：127A / 128A
页数：2
相关论文
共 50 条
  • [1] Addition of Peginterferon Alfa-2b During Long-term Nucleos(t)ide Analogue Therapy Increases HBeAg Seroconversion and HBsAg Decline - Week 48 Results From a Multicenter Randomized Controlled Trial (PEGON Study)
    Chi, Heng
    Xie, Qing
    Zhang, Ning-Ping
    Qi, Xun
    Liang, Chen
    Guo, Simin
    Guo, Qing
    Arends, Pauline
    Wang, Ji-Yao
    Verhey, Elke
    de Knegt, Robert J.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2014, 60 : 1106A - 1106A
  • [2] Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study)
    Farag, Mina S.
    van Campenhout, Margo J. H.
    Sonneveld, M. J.
    Fung, Scott
    van Erpecum, Karel J.
    Wong, David K.
    Verhey, Elke
    de Man, Robert
    De Knegt, Robert J.
    Brouwer, Johannes T.
    Baak, Hubertus C.
    Feld, Jordan J.
    Liem, Kin Seng
    Boonstra, Andre
    Hansen, Bettina E.
    Janssen, Harry L. A.
    JOURNAL OF VIRAL HEPATITIS, 2024, 31 (04) : 197 - 207
  • [3] A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
    van Boemmel, Florian
    Stein, Kerstin
    Heyne, Renate
    Petersen, Joerg
    Buggisch, Peter
    Berg, Christoph
    Zeuzem, Stefan
    Stallmach, Andreas
    Sprinzl, Martin
    Schott, Eckart
    Pathil-Warth, Anita
    von Arnim, Ulrike
    Keitel, Verena
    Lohmeyer, Juergen
    Simon, Karl-Georg
    Trautwein, Christian
    Trein, Andreas
    Hueppe, Dietrich
    Cornberg, Markus
    Lammert, Frank
    Ingiliz, Patrick
    Zachoval, Reinhart
    Hinrichsen, Holger
    Zipprich, Alexander
    Klinker, Hartmuth
    zur Wiesch, Julian Schulze
    Schmiedeknecht, Anett
    Brosteanu, Oana
    Berg, Thomas
    JOURNAL OF HEPATOLOGY, 2023, 78 (05) : 926 - 936
  • [4] A comment on "A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B"
    Wan, Yue-Meng
    Wu, Hua -Mei
    Huang, Song-Quan
    Li, Hua -Yu
    Yin, Hong -Jing
    JOURNAL OF HEPATOLOGY, 2024, 80 (05) : e229 - e230
  • [5] HBSAG LOSS IS ENOUGH TO DISCONTINUE LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN REAL PRACTICE?
    Fasano, M.
    Ciarallo, M.
    Niro, G.
    Fontana, R.
    Cozzolongo, R.
    Maci, A.
    Carraturo, I.
    Miglietta, A.
    Angarano, G.
    Santantonio, T.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E12 - E12
  • [6] INTERRUPTION OF NUCLEOS(T)IDE ANALOGUE THERAPY FOR HBeAg-NEGATIVE CHRONIC HEPATITIS B - A NEW CONCEPT TO ACHIEVE HBsAg DECLINE?
    Siederdissen, C. Hoener Zu
    Rinker, F.
    Falk, C.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Mix, C.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A.
    Cornberg, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S571 - S572
  • [7] CHANGES OF SERUM HBSAG LEVELS IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS UNDER LONG-TERM THERAPY WITH NUCLEOS(T)IDE ANALOGUE(S)
    Papatheodordis, George V.
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Margariti, Ekaterini
    Exarchos, Xenofon
    Kokkonis, George
    Papaioannou, Christos
    Akriviasdis, Evangelos A.
    Manesis, Emanuel K.
    HEPATOLOGY, 2011, 54 : 1054A - 1054A
  • [8] HBSAG LOSS IS ENOUGH TO DISCONTINUE LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN REAL PRACTICE?
    Fasano, M.
    Ciarallo, M.
    Niro, G.
    Fontana, R.
    Cozzolongo, R.
    Maci, A.
    Carraturo, I.
    Miglietta, A.
    Angarano, G.
    Santantonio, T.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S370 - S371
  • [9] Reply to: "A comment on 'A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B'"
    van Boemmel, Florian
    Berg, Thomas
    JOURNAL OF HEPATOLOGY, 2024, 80 (05) : e230 - e231
  • [10] Final Results of Peginterferon Alfa-2b Add-on during Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients - a Multicenter Randomized Controlled Trial (PEGON Study)
    Chi, Heng
    Xie, Qing
    Zhang, Ning-Ping
    Qi, Xun
    Liang, Chen
    Guo, Simin
    Guo, Qing
    Arends, Pauline
    Wang, Jiyao
    Verhey, Elke
    de Knegt, Robert J.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2015, 62 : 1183A - 1183A
12345